Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

5:21 PM ET 8-K
Capital Raise Flyte Aviation, Inc. VJET

Flyte Aviation Capital Raise of $2.05M

Flyte Aviation, Inc. entered into an agreement with existing investors to sell 2,050 shares of Series C-4 Convertible Preferred Stock for gross proceeds of $2.05 million. The preferred shares are convertible into common stock at a price of $1.00 per share. Additionally, the company reduced the conversion price of all outstanding Series C, Series D, and Series J preferred stock to $1.00 per share.

Value
$2.05M
5:21 PM ET 8-K
Nasdaq/NYSE Compliance Notice Streamex Corp. STEX

Streamex Nasdaq/NYSE Compliance Notice

Streamex Corp. received a deficiency notice from Nasdaq on October 7, 2026, for failing to maintain the minimum bid price of $1.00 per share over 30 consecutive business days. The company has until April 5, 2027, to regain compliance, which requires the stock to close at $1.00 or higher for at least ten consecutive business days. The notice does not have an immediate effect on the listing of the company's common stock (STEX).

Counterparty
Nasdaq
Term
180 days
5:20 PM ET Form 4
Insider Selling PTC Therapeutics, Inc. PTCT

PTC Therapeutics Director Michael Schmertzler Sells $155K of Stock

Michael Schmertzler, Director, sold 2,447 shares of PTC Therapeutics, Inc. at $63.38 a share, worth $155K in total on Oct 7, 2026. Shares held after the trade: 1,294,147 (-0.2%).

Value
$155K
Shares
2,447
Price
$63.38
Role
Director
Holding change
-0.2%
Trade date
Oct 7, 2026
5:19 PM ET 8-K
Other 8-K Filing Serina Therapeutics, Inc. SER

Serina Therapeutics Other 8-K Filing

Serina Therapeutics filed a Certificate of Elimination with the State of Delaware to remove the Series A Convertible Preferred Stock designation from its charter. All previously issued shares of Series A Preferred Stock have been converted into common stock, and the eliminated shares have returned to the status of authorized but unissued preferred stock.

5:19 PM ET 8-K
Capital Raise Arrive AI Inc. ARAI

Arrive AI Capital Raise

Arrive AI Inc. closed a $250,000 private placement (PIPE) with an accredited investor, issuing 384,615 shares of common stock and warrants at a purchase price of $0.65 per unit. The investment was priced at a 213% premium to the company's recent trading price, and the investor expressed interest in evaluating up to $10 million in additional future financing.

5:17 PM ET Form 4
Insider Selling Hershey Co HSY

Hershey Insider Hershey Trust Co Trustee in Trust for Milton Hershey School Sells $3.25M of Stock

Hershey Trust Co Trustee in Trust for Milton Hershey School sold 19,999 shares of Hershey Co at $160.86 to $163.15 a share (average $162.36) in 6 transactions, worth $3.25M in total between Oct 8, 2026 and Oct 9, 2026. Shares held after the trade: 616,120 (-1.3%).

Value
$3.25M
Shares
19,999
Average price
$162.36
Holding change
-1.3%
Trade date
Oct 8, 2026 to Oct 9, 2026
5:17 PM ET 8-K
Other 8-K Filing Volato Group, Inc. SOAR

Volato Group Other 8-K Filing

Volato Group entered into a Common Stock Purchase Agreement with DFU, LLC to establish an equity line of credit (ELOC) facility. The agreement grants the company the right, but not the obligation, to sell up to $1 billion of Class A common stock over a 36-month period at prices determined by future market formulas. As of the filing date, no shares have been sold and no proceeds have been raised under this facility.

Counterparty
DFU, LLC
Term
36 months
5:16 PM ET 8-K
Other 8-K Filing Quantum Cyber N.V. QUCY

Quantum Cyber Other 8-K Filing

Quantum Cyber N.V. entered into a sales agreement with Titan Partners Securities LLC to establish an at-the-market (ATM) offering program for up to $100 million of its ordinary shares. The company is not obligated to sell any shares and no shares have been sold as of the filing date. Proceeds, if any, are intended for capital expenditures, software development, and potential strategic acquisitions.

Counterparty
Titan Partners Securities LLC
5:16 PM ET 8-K
Executive Compensation Vistagen Therapeutics, Inc. VTGN

Vistagen Therapeutics Executive Compensation

Vistagen Therapeutics has amended and restated its Executive Severance Plan to expand the circumstances under which eligible employees, including executive officers, receive benefits. The new plan now provides cash severance and COBRA premiums for terminations without cause regardless of whether a change in control occurs, whereas the previous plan required a change in control event.

5:16 PM ET 8-K
Investor Presentation Mobix Labs, Inc MOBX

Mobix Labs Investor Presentation

Mobix Labs, Inc. filed an investor presentation dated October 8, 2026, regarding its national security platform initiative. The presentation was used during an investor update call to provide strategic highlights and operational updates to shareholders.

5:16 PM ET 8-K
Nasdaq/NYSE Compliance Notice Artelo Biosciences, Inc. ARTL

Artelo Biosciences Nasdaq/NYSE Compliance Notice

Artelo Biosciences was identified as one of approximately 180 companies currently below Nasdaq's new $5 million minimum Market Value of Listed Securities (MVLS) requirement. While the rule is currently under a temporary stay and subject to proposed modifications, the company is monitoring the situation and considering potential actions to maintain compliance, such as capital raises or expense management.

Counterparty
Nasdaq
5:16 PM ET 8-K
Shareholder Meeting Moleculin Biotech, Inc. MBRX

Moleculin Biotech Shareholder Meeting

Moleculin Biotech held its 2026 Annual Meeting of Stockholders where shareholders elected five directors and ratified Grant Thornton LLP as the independent auditor. Stockholders also approved an amendment to the 2024 Equity Plan to increase the authorized shares by 3,861,894 and passed a non-binding advisory resolution on executive compensation.

5:14 PM ET 8-K
Leadership Change AgEagle Aerial Systems Inc. UAVS

AgEagle Aerial Systems Leadership Change

Brent Pope, the Chief Operating Officer of AgEagle Aerial Systems Inc., notified the company of his intention to retire effective November 30, 2026. The company stated the retirement was not due to any disagreements and it will commence a search for a successor.

5:12 PM ET 8-K
Other 8-K Filing Niki BioSolutions, Inc. NIKI

Niki BioSolutions Other 8-K Filing

Niki BioSolutions, Inc. entered into an At the Market Offering Agreement with H.C. Wainwright & Co. and Brookline Capital Markets to establish an ATM program. The company may sell shares of common stock from time to time up to an aggregate maximum offering price of $1.396 million, though no shares have been sold as of the filing date.

Counterparty
H.C. Wainwright & Co., LLC
5:10 PM ET 8-K/A
Business Update Invesco Ltd. IVZ

Invesco Business Update

Invesco Ltd. reported preliminary month-end assets under management (AUM) of $2,537.8 billion for September 30, 2026, representing a 0.9% decrease from the prior month. The decline was driven by $16 billion in unfavorable market returns and $5.7 billion in money market net outflows, partially offset by reinvested distributions.

Term
September 2026
5:10 PM ET Form 4
Insider Selling Cerence Inc. CRNC

Cerence CFO Antonio Rodriquez Sells $613K of Stock

Antonio Rodriquez, CFO, sold 76,614 shares of Cerence Inc. at $8.00 a share, worth $613K in total on Oct 7, 2026. Shares held after the trade: 500,632 (-13.3%).

Value
$613K
Shares
76,614
Price
$8.00
Role
CFO
Holding change
-13.3%
Trade date
Oct 7, 2026
5:10 PM ET Form 4
Insider Buying Cerence Inc. CRNC

Cerence CFO Antonio Rodriquez Buys $14K of Stock

Antonio Rodriquez, CFO, bought 2,000 shares of Cerence Inc. at $7.02 a share, worth $14K in total on Feb 15, 2026. Shares held after the trade: 577,246 (+0.3%).

Value
$14K
Shares
2,000
Price
$7.02
Role
CFO
Holding change
+0.3%
Trade date
Feb 15, 2026
5:09 PM ET Form 4
Insider Selling Robinhood Ventures Fund I RVI

Robinhood Ventures Fund I Insider Robinhood Markets Inc. Sells $352K of Stock

Robinhood Markets Inc. sold 13,434 shares of Robinhood Ventures Fund I at $26.08 to $26.46 a share (average $26.23) in 2 transactions, worth $352K in total between Oct 7, 2026 and Oct 8, 2026. Shares held after the trade: 12,959,949 (-0.1%).

Value
$352K
Shares
13,434
Average price
$26.23
Holding change
-0.1%
Trade date
Oct 7, 2026 to Oct 8, 2026
5:08 PM ET
Earnings Call Live Nation Entertainment, Inc. LYV ▶ Call

Live Nation Entertainment Earnings Call: Key Takeaways

Live Nation reports record demand with double-digit fan growth expected for 2026, driven by international expansion and a strong second-half concert slate.

5:08 PM ET Form 4
Insider Selling Okta, Inc. OKTA

Okta CAO Shibu Ninan Sells $3.2M of Stock

Shibu Ninan, CAO, sold 14,677 shares of Okta, Inc. at $216.35 to $220.00 a share (average $217.80) in 4 transactions, worth $3.2M in total between Oct 7, 2026 and Oct 8, 2026. Shares held after the trade: 11,071 (-15.3%).

Value
$3.2M
Shares
14,677
Average price
$217.80
Role
CAO
Holding change
-15.3%
Trade date
Oct 7, 2026 to Oct 8, 2026
5:08 PM ET Form 4
Insider Selling Covista Inc. CVSA

Covista Chairman & CEO Stephen W. Beard Sells $1.08M of Stock

Stephen W. Beard, Chairman & CEO, sold 8,306 shares of Covista Inc. at $130.37 to $130.77 a share (average $130.59) in 2 transactions, worth $1.08M in total between Oct 8, 2026 and Oct 9, 2026. Shares held after the trade: 469,158 (-1.0%).

Value
$1.08M
Shares
8,306
Average price
$130.59
Role
Chairman & CEO
Holding change
-1.0%
Trade date
Oct 8, 2026 to Oct 9, 2026
5:07 PM ET 10-K
Financial Results alpha-En Corp ALPE

alpha-En FY 2025 Results: Net Loss of $1.11M, Loss Narrows

alpha-En Corp is a development-stage company focused on its proprietary Room Temperature Lithium Extraction (RLE) technology, which achieved a roll-to-roll demonstration in November 2025. The company currently generates no commercial revenue and is funded primarily through federal and state government awards (DOE, DOD, NYSERDA) and private investment from its principal stockholder, NRL.

Key figure
Net loss $1.11M
5:07 PM ET Form 4
Insider Selling Cerence Inc. CRNC

Cerence CEO Brian M. Krzanich Sells $174K of Stock

Brian M. Krzanich, CEO, sold 21,703 shares of Cerence Inc. at $8.00 a share, worth $174K in total on Oct 7, 2026. Shares held after the trade: 1,700,388 (-1.3%).

Value
$174K
Shares
21,703
Price
$8.00
Role
CEO
Holding change
-1.3%
Trade date
Oct 7, 2026
5:07 PM ET Form 4
Insider Selling Cerence Inc. CRNC

Cerence EVP, Chief Revenue Officer Christian Mentz Sells $391K of Stock

Christian Mentz, EVP, Chief Revenue Officer, sold 48,923 shares of Cerence Inc. at $8.00 a share, worth $391K in total on Oct 7, 2026. Shares held after the trade: 244,551 (-16.7%).

Value
$391K
Shares
48,923
Price
$8.00
Role
EVP, Chief Revenue Officer
Holding change
-16.7%
Trade date
Oct 7, 2026
5:06 PM ET 8-K
Financial Results SolarMax Technology, Inc. SMXT

SolarMax Technology Financial Results

SolarMax Technology reported Q2 2026 revenue of $10.2 million, a 49% increase year-over-year, and a significant rise in gross profit to $2.4 million. The company recorded a net loss of $4.7 million, which was primarily driven by a one-time $4.3 million legal judgment expense related to its China segment. Management highlighted growth in industrial EPC services and large-scale energy storage as key strategic focuses.

Term
Q2 2026

“Our second quarter results demonstrate continued year-over-year progress, with revenue increasing 49% and gross profit rising to $2.4 million.”

David Hsu, CEO of SolarMax

“While a one-time $4.3 million legal judgment expense relating to our China segment contributed to a higher net loss, we achieved substantial improvement in gross profit and gross margin compared with the prior-year period.”

David Hsu, CEO of SolarMax
5:06 PM ET Form 4
Insider Selling Immunovant, Inc. IMVT

Immunovant CTO Jay S. Stout Sells $122K of Stock

Jay S. Stout, CTO, sold 3,809 shares of Immunovant, Inc. at $32.06 a share, worth $122K in total on Oct 7, 2026. Shares held after the trade: 201,532 (-0.8%).

Value
$122K
Shares
3,809
Average price
$32.06
Role
CTO
Holding change
-0.8%
Trade date
Oct 7, 2026
5:05 PM ET Form 4
Insider Buying AH Realty Trust, Inc. AHRT

AH Realty Trust Insider Theodore Bigman Buys $11.2K of Stock

Theodore Bigman bought 1,879 shares of AH Realty Trust, Inc. at $5.96 a share, worth $11.2K in total on Oct 8, 2026. Shares held after the trade: 84,196 (+2.3%).

Value
$11.2K
Shares
1,879
Price
$5.96
Holding change
+2.3%
Trade date
Oct 8, 2026
5:05 PM ET Form 4
Insider Selling Block, Inc. XYZ

Block Insider Anthony Mathew Eisen Sells $1.36M of Stock

Anthony Mathew Eisen sold 18,000 shares of Block, Inc. at $75.17 to $75.75 a share (average $75.42) in 3 transactions, worth $1.36M in total between Oct 7, 2026 and Oct 9, 2026. Shares held after the trade: 1,290,672 (-0.5%).

Value
$1.36M
Shares
18,000
Average price
$75.42
Holding change
-0.5%
Trade date
Oct 7, 2026 to Oct 9, 2026
5:05 PM ET Form 4
Insider Selling Immunovant, Inc. IMVT

Immunovant CLO Tuyl Christopher Van Sells $42.5K of Stock

Tuyl Christopher Van, CLO, sold 1,327 shares of Immunovant, Inc. at $32.06 a share, worth $42.5K in total on Oct 7, 2026. Shares held after the trade: 175,218 (-0.8%).

Value
$42.5K
Shares
1,327
Price
$32.06
Role
CLO
Holding change
-0.8%
Trade date
Oct 7, 2026
5:05 PM ET Form 4
Insider Selling Globalfoundries Inc. GFS

Globalfoundries CLO Samak L. Azar Sells $16.4K of Stock

Samak L. Azar, CLO, sold 335 shares of Globalfoundries Inc. at $49.01 a share, worth $16.4K in total on Oct 8, 2026. Shares held after the trade: 8,459 (-3.8%).

Value
$16.4K
Shares
335
Price
$49.01
Role
CLO
Holding change
-3.8%
Trade date
Oct 8, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.